Scroll down or click here for full Conference Calendar.
The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to increase patient centricity, aid self-administration and deliver biologics that have large-volumes and novel formulations. This year’s conference will explore the exciting advances in the combination product drug delivery space and a future outlook exploring how pharma, device developers and regulators can work together to encourage innovation.
SAE’s 2nd annual Transdermal and Microneedle Drug Delivery conference will explore advances in microneedle diagnostics through case studies and real-world examples, whilst engaging in modern strategies for topical and transdermal drug delivery. The two-day agenda offers you peer-to-peer networking with CEO’s, Senior Vice presidents, Directors of Delivery Technologies, Heads of Product Development and many more.
The event aims to help ophthalmic drug developers overcome translational challenges of developing novel long-lasting ophthalmic therapies. The comprehensive agenda, built by experts in will provide you with a wealth of invaluable knowledge to tackle challenges with sustained release formulation, biomarkers for ocular inflammation, ocular devices, alternative administration routes, preclinical models and designing clinical trials.
In 2023 we will see the return of SAE Media Group’s RNA Therapeutics conference to a live in-person event, showcasing an update on mRNA therapeutic applications, coupled with an industry outlook of the field. We will also explore the latest trends in novel RNA therapies, including developments in AI modelling and small molecule modulation of RNA.
Don't miss the chance to meet over 130 leading specialists from all tiers of the medical device manufacturing supply chain. There will also be various Learning Programmes for medical device manufacturers, including the Women in MedTech Forum and two new features this year - the Young MedTech Entrepreneurs Assembly and the Future of Medical Device Design Congress.
Overcoming challenges in formulation, device design and patient compliance are the keys to your organization's ability to leverage products in the inhalation drug delivery market. Pharma Ed's Inhalation Drug Delivery Summit brings together today's leading researchers from both industry and academia to share the latest knowledge in drug and device development, from pre-clinical R&D through phase trials.
The 2nd Annual LNP Formulation & Process Development meeting will welcome 350+ LNP Biology, Chemistry, Formulation & Process Development, Tech Ops & Manufacturing experts. With expanded content, the three-track summit will now offer the most comprehensive content, briefing attendees on the end-to-end LNP development journey for this non-viral delivery vehicle for delivering various payloads to target cells and organs.
Regulators in North America and Europe are requiring stricter standards for the manufacture and safety testing for combination products. Pharma Ed’s Combination Products Summit features expert insight into CP development and the complex quality, safety, and regulatory compliance issues facing the CP market.
This conference will examine the safety, quality and regulatory issues. It will focus closely on the keys to satisfying recent revisions to several applicable USP chapters, FDA guidances & other international regulatory requirements for best practices in materials and chemistry characterisation for drugs, biologics, delivery systems, and primary & secondary packaging.
Canna Pharma links current knowledge and practice in the pharmaceutical and cannabis industries, providing a forum for scientific dialogue and collaboration to enlarge the scope of safe and effective therapies in this growing market. Join the discussion to advance medicinal cannabis science, and network with research/discovery scientists, product developers, cultivators, processors, quality assurance professionals, and policy makers
The drug delivery industry is on the threshold of bringing into commercial production a new generation of transformative skin-mediated delivery systems. That is why you cannot afford to miss Pharma Ed’s Microneedle & Transdermal Drug Delivery Forum. Leading researchers from industry and academia come together to share the most recent advances in the design, formulation, and delivery of skin-mediated therapies and vaccines.
Regulators in North America and Europe are requiring stricter standards for environmental monitoring systems, facility cleaning and disinfectant qualification, aseptic cleanroom operations, filtration, sterilisation, and aseptic process simulation (or media fill). The Aseptic Processing Summit includes expert insight into the robust aseptic processing requirements facing the industry, and covers implementation and management of best practice aseptic, barrier, containment, and aseptic technologies.
Projected to hit US$8 billion by the end of 2024 in the US alone, the market for PFS and autoinjectors continues to grow fast. Numerous advantages such as ease of administration, enhanced safety, reduced risk of contamination, and accuracy of dosing make PFS & autoinjectors attractive. Growth in the biologics market, rising preference for self-administrations which use PFS, pen injectors, and autoinjectors, are propelling the growth. This is why you cannot afford to miss Pharma Ed Resources’ Pre-filled Syringes & Auto-Injectors Forum, which brings together thought-leaders and key decision makers over two days.
DRUG DELIVERY CONFERENCES 2022/23
THIS CALENDAR REPRESENTS THE MOST RELIABLE, MOST COMPLETE SINGLE SOURCE FOR LISTINGS
OF QUALITY DRUG DELIVERY-RELEVANT CONFERENCES WORLDWIDE
UPDATED: November 28th, 2022
** Bold denotes events with which ONdrugDelivery is a Media Partner **
To request inclusion of a drug delivery (or drug delivery-related) event here, email: email@example.com.
Important Note: This conference calendar is for information only and lists events organised by third parties. The publisher, Frederick Furness Publishing Ltd, does not organise any of the events listed. Due care has been used in producing this document, but the Publisher makes no claim that it is free from errors. Nor does the Publisher accept liability for the consequences of any decision or action taken (or not taken) as a result of any information presented herein.